Stay updated on Pomalidomide Combo for RRMM Clinical Trial
Sign up to get notified when there's something new on the Pomalidomide Combo for RRMM Clinical Trial page.

Latest updates to the Pomalidomide Combo for RRMM Clinical Trial page
- Check6 days agoChange DetectedThe page footer now displays the revision tag v3.6.2, replacing the prior v3.6.0.SummaryDifference0.0%

- Check13 days agoChange DetectedNew date entries were added and older entries removed in the Study Record Dates. These changes reflect recent update activity on the study page rather than changes to the trial data.SummaryDifference0.1%

- Check20 days agoChange DetectedThe study page now explicitly states that recruitment has closed. New help sections and navigation, including How to Read a Study Record, Common Questions, and How to Join a Study, were added, and the page revision note updated to v3.6.0; the Intervention/Treatment header formatting was adjusted.SummaryDifference0.3%

- Check27 days agoChange DetectedAn updated site revision label 'Revision: v3.5.5' appears on the page, replacing the previous 'Revision: v3.5.4'. This metadata change does not modify the study data or user-visible content.SummaryDifference0.1%

- Check34 days agoChange DetectedThe page now includes related topic links for Multiple Myeloma and MedlinePlus Genetics, offering quick access to broader background information alongside the study details. This enhancement improves contextual resources without modifying the study data or required user actions.SummaryDifference0.1%

- Check41 days agoChange DetectedThe study record now shows a Results Posted entry for 2026-05-22 and adds a location in Fukuoka, Japan. The outcomes section is expanded with explicit ORR criteria and definitions for PFS, OS, DoR, TTR, and TTP, including their timeframes.SummaryDifference2%

Stay in the know with updates to Pomalidomide Combo for RRMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pomalidomide Combo for RRMM Clinical Trial page.